Table 5. Clinical data and comparison between HMPV and rhinovirus single infections.

	HMPV N = 133	RHINOVIRUS N = 651	P	OR (IC 95%)
Sex: male	77 (57.9%)	398(61%)	0.357	0.856(0.615–1.192)
Age ± SD (months)*	14.37 ± 20.85	25.7±27.9	<0.001
Fever ≥ 38°	90 (67.7%)	272(41.8%)	<0.001	2.386(1.674–3.385)
Maximum Tª	38.83 ± 0.62	38.7±0.6	0.08
Days of fever*	2.6 ± 1.6	2.3±1.7	0.127
SatO2 < 95%	83 (62.4%)	330(51%)	0.021	1.486(1.056–2.090)
Days of ipoxia*	2.6 ± 1.8	1.9±1.7	0.001
Days of hospitalization*	4.2 ± 2.1	3.4±2.1	<0.001
X-ray:
Infiltrate	43 (48.3%)	178(43.1%)	0.440	1.152(0.805–1.648)
Normal	46 (51.7%)	235(57%)
Leukocytes/mm3 *	11732± 4446	19609± 66000	0.35
C-reactive protein (mg/dL)*	34 ± 38	53 ± 88	0.009
Diagnosis:			0.30
Recurrent wheezing/ asthma.	65 (60.7%)	530 (57.3%)
Bronchiolitis	32 (29.9%)	253(27.4%)
Pneumonia	9 (8.4%)	88(9.5%)
Laryngitis	1 (0.9%)	14(2.4%)
Prematurity	20 (15.2%)	80(12.4%)	0.191	1.341(0.871–2.066)
Antibiotic treatment	34 (25.6%)	141(21.7%)	0.321	1.209(0.833–1.754)
ICU admission	4 (2.2%)	20 (2.1%)	0.477

*Mean ± standard deviation (SD)

HMPV: human metapneumovirus.